Download presentation
Presentation is loading. Please wait.
1
World Kidney Day 2016: Kidney Disease & Children
World Kidney Day 2016: Kidney Disease & Children. Act Early to Prevent It!
2
World Kidney Day 2016: Kidney Disease & Children
World Kidney Day 2016: Kidney Disease & Children. Act Early to Prevent It! Kidney disease affects millions of people worldwide, including many children who may be at risk at an early age. It is therefore crucial that we encourage and facilitate education, early detection and a healthy life style in children, to fight the increase of preventable kidney diseases and to treat children with inborn and acquired disorders of the kidneys worldwide.
3
Pediatric Kidney Disease – An Update
Edited by the ASPN Clinical Affairs Committee
4
Hypertension (HTN) Tammy Brady, MD, PhD
Johns Hopkins Children’s Center
5
HTN: Background Health care providers: Do not routinely measure BP
Epidemiology 1970’s and 1980’s: 0.3%-1.2% of children had HTN Current Estimates: 3-5% of all children have HTN 3-24% of all children are pre-hypertensive Prehypertension hypertension at a rate of 7% per year 20-47% of obese children are hypertensive Prevalence of HTN in children increases with increasing BMI percentile Underestimate of disease? Providers don’t routinely measure BP Providers don’t routinely recognize BP elevations Health care providers: Do not routinely measure BP 2/3 of the time during WCV 1/3 of the time during sick visits Under-recognize elevated BP Over 6 months: 39% pediatric visits had an elevated BP 87% of these encounters were unrecognized by providers
6
HTN: Definition Sustained elevation in BP ≥95th percentile or ≥140/90
Any BP ≥ 90th percentile (or ≥120/80) should be repeated manually x2, with the average recorded 95th percentile 90th percentile or 120/80 99th percentile 99th percentile + 5 mmHg NORMAL BP PRE-HYPERTENSION STAGE 1 HYPERTENSION STAGE 2 HYPERTENSION Children 1-17 years 140/90 120/80 160/100 NORMAL BP PRE-HYPERTENSION STAGE 1 HYPERTENSION STAGE 2 HYPERTENSION Adolescents ≥18 years normal blood pressure increases with age, height and BMI Presence of systemic illness associated with HTN (neurofibromatosis, tuberous sclerosis)
7
HTN: Technique is important!
8
HTN: New developments Update!
Updated guideline for the evaluation of elevated blood pressure in children and adolescents Sponsored by the American Academy of Pediatrics Multidisciplinary committee Increased CVD risk with pre-hypertension? Need for lower BP thresholds to decrease CVD risk? SHIP-AHOY The Population project -> investigate BP thresholds for development of hypertensive target organ damage (TOD) The Clinical Project -> characterize the ambulatory BP and metabolic phenotype best predicting TOD. The Basic Project -> investigate epigenetic changes that influence the development of TOD in youth with HTN.
9
HTN: New developments Ability to identify target organ damage
Echocardiography – measure LVMI, RWT Detect LVH (eccentric and concentric) - > initiate antihypertensive therapy Detect concentric remodeling Neurocognitive testing – assess executive function, attention Radial artery applanation tonometry – measure central vascular pressure More accurate predictor of CVD outcome than peripheral BP Peripheral pressure does not accurately reflect central pressure 2/2 pressure amplification BP meds have different effects on central BP despite similar effect on peripheral BP Pulse Wave Velocity – measure central arterial stiffness Augmentation Index – measure peripheral arterial stiffness
10
HTN: New developments Obesity prevalence and role in HTN HYPERTENSION
Prevalence of obesity in 2-19 years olds remains high at 17% and has not changed significantly based on NHANES data. BP tables: 21% of this normative data comes from obese/ overweight children Obstructive sleep apnea common Dysfunctional adipocyte -> imbalance in expression of pro- and anti-inflammatory adipokines -> Hypertension Adipose Tissue Dysfunction: Macrophage infiltration Increased FFA Hyperleptinemia Adiponectin deficiency Increased resistin RAAS hormone secretion Mineralocorticoid stimulating factor RAAS Activation SNS Activation Oxidative stress and Inflammation Endothelial dysfunction Impaired pressure natriuresis Vascular hypertrophy HYPERTENSION Dorresteijn et al, Obesity Reviews, 2012.
11
HTN: Key Points J Pediatr. 2015 Sep 2. doi: 10.1016
Role of healthy lifestyle - nature and nurture Resolution of elevated BP in transition from childhood to adulthood appeared to be partially determined by modifiable factors including “fruit and vegetable intake, physical activity, cardiorespiratory fitness, alcohol consumption, smoking, and socioeconomic status” BP in childhood and the gain in BMI from childhood to adulthood are significant predictors of adult hypertension in both genders. Genetic risk score in women and risky alcohol consumption in men are independently related with the risk of adult hypertension. Meeting current physical activity recommendations (≥ 60 minutes/day) is able to attenuate the deleterious effect of genetic polymorphism on systolic blood pressure in European adolescents. J Pediatr Sep 2. doi: PLoS One Oct 14;9(10):e
12
HTN: Therapies
13
HTN: Therapies PEDIATRICS Volume 128, Supplement 5, December 2011 This publication provides comprehensive tables regarding anti-hypertensive medications in children. Example: The Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report published in Pediatrics in 2011 has two tables of “Antihypertensive Medications with Pediatric Experience” Likely more to be added to this table with the Food and Drug Association Modernization Act (FDAMA) - Some medications now have FDA approved pediatric labelling - New clinical trials have provided needed data regarding drug dosing and metabolism
14
HTN: Summary Hypertension in children is likely underrecognized due to infrequent and improper measurement Proper measurement technique is vital! Studies are underway to better understand the long-term impact of hypertension in children Appropriate lifestyle modifications and pharmacologic therapy will be the key to limiting long-term health effects
15
Happy World Kidney Day 2016! Your pediatric nephrology community continues to work hard to improve clinical care, foster education, and advance the science regarding kidney disease in children! We appreciate your support and all you do for children’s health care!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.